UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000009476
Receipt number R000011130
Scientific Title A phase II study to evaluate efficacy and safety of Bevacizumab combined with Cisplatin and S-1 for Advanced Non-Squamous Non-Small-Cell Lung Cancer
Date of disclosure of the study information 2013/02/01
Last modified on 2019/04/20 14:20:27

No. Disposal Last modified on Item of update
1 Insert 2012/12/04 14:01:07
2 Update 2012/12/12 15:31:43 Key exclusion criteria
3 Update 2012/12/27 10:06:26 Public title
Acronym
Acronym
4 Update 2012/12/27 10:06:58 Narrative objectives1
Narrative objectives1
5 Update 2012/12/27 10:11:19 Interventions/Control_1
Interventions/Control_1
Key inclusion criteria
Key exclusion criteria
6 Update 2013/01/09 15:49:37 Key inclusion criteria
Key inclusion criteria
7 Update 2013/01/11 15:03:16 Condition
8 Update 2013/01/11 15:05:04 Interventions/Control_1
Interventions/Control_1
9 Update 2013/01/29 10:46:04 Public title
Acronym
Acronym
10 Update 2013/01/29 10:47:37 Organization
Organization
Division name
Division name
11 Update 2013/04/11 10:53:18 Interventions/Control_1
Interventions/Control_1
12 Update 2013/07/04 11:28:02 Recruitment status
13 Update 2013/12/04 10:59:47 TEL
Email
Last name of contact person
Last name of contact person
Address
Address
Email
Email
14 Update 2014/12/04 09:53:01 Name of person sending information
Name of person sending information
15 Update 2014/12/04 10:02:49 Name of person sending information
Name of person sending information
16 Update 2014/12/04 10:05:39 Name of person sending information
17 Update 2015/02/04 09:20:57 Email
Email1
18 Update 2015/02/04 09:21:20 Recruitment status
19 Update 2019/04/20 14:19:49 Date of IRB
Last follow-up date
Date analysis concluded
20 Update 2019/04/20 14:20:27 Recruitment status